Physician profile
Wayne L Gray
NPI 1588633663
$589.17
in general payments reported to CMS, 2019-2025
14 companies · $206 in 2025
The $206 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $113 · 2020: $13.48 · 2021: $40.44 · 2022: $32.92 · 2023: $40.16 · 2024: $143 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $389.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $389.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $163.99 | 2019-2025 | Cardiomems |
| Novartis Pharmaceuticals Corporation | $139.10 | 2022-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $74.72 | 2024 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.54 | 2023-2024 | Jardiance |
| Philips North America LLC | $42.05 | 2022-2025 | Lm Undivided |
| Penumbra, INC. | $36.79 | 2023-2024 | Penumbra System, Indigo System |
| Astrazeneca Pharmaceuticals Lp | $29.52 | 2020-2021 | |
| Inspire Medical Systems, INC. | $20.40 | 2025 | Inspire |
| E.R. Squibb & Sons, L.L.C. | $19.87 | 2025 | Eliquis |
| Pfizer INC. | $15.19 | 2025 |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wayne Gray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.